ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

DCPC Concepts Approved

September 27, 1985

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

Abstracts Of Papers From ASCO Meeting

April 7, 1978

NIH To Correct Factual Errors In Jackson Lab Policy Statement

August 18, 1989